Xcout Intel
Ipsen
Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.
Subscribe to see Ipsen’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ipsen at a glance
Ipsen is a pharmaceuticals company headquartered in United Kingdom, founded in 2008. Xcout tracks 27 named people at Ipsen, including David Loew (Chief Executive Officer). Xcout recorded 149 job postings from Ipsen in the last 90 days.
Ipsen leadership
- David LoewChief Executive Officer
- Marc de GaridelChairperson of the Board of Directors
- Aymeric Le ChatelierExecutive Vice President Chief Financial Officer
- Mari ScheiffeleExecutive Vice President Chief Product Officer and Head of GPPS
- Josep CatllàExecutive Vice President Chief Corporate Affairs Officer
- Philippe Lopes-FernandesExecutive Vice President Chief Business Officer
21 more named people on record for Ipsen, with roles, board committees and tenure — see the full roster →
Hiring at Ipsen
Xcout recorded 149 job postings from Ipsen in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Ipsen's hiring signals →
Hiring vs the trend
Based on 238 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 168 enterprise healthcare companies.
This describes a hiring pattern — how often Ipsen’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Tech stack
Ipsen competitors
A few of Ipsen's closest competitors — see the full list of competitors and alternatives →
Servier is an international pharmaceutical company that researches, develops, and provides medical treatments primarily focused on oncology, cardio-metabolic diseases, and neurology. The company serves patients globally by delivering therapeutic innovations and advancing research in areas such as rare diseases and chronic conditions.
UCB is a global biopharmaceutical company that researches, develops, and delivers medicines and solutions for patients living with severe neurological and autoimmune conditions. It serves individuals with chronic and rare diseases as well as healthcare professionals through treatments, clinical studies, and support services.
Sanofi is a research-driven, artificial intelligence-powered biopharmaceutical company that develops and manufactures innovative medicines and vaccines. It serves patients globally across multiple therapeutic areas, including immunology, neurology, oncology, rare diseases, and general medicines.
Novartis is a global healthcare company that researches, develops, and manufactures innovative medicines across therapeutic areas such as oncology, immunology, neuroscience, and cardiovascular diseases. The company serves patients, healthcare professionals, and healthcare systems worldwide by providing pharmaceutical treatments and managing clinical trials.
Bristol Myers Squibb is a global biopharmaceutical company that researches, develops, and delivers innovative medicines to help patients prevail over serious diseases. The company focuses on therapeutic areas including oncology, hematology, neuroscience, immunology, and cardiovascular research.
Camurus is an international pharmaceutical company that develops and provides innovative, long-acting treatments for patients with severe and chronic conditions. The company focuses on therapeutic areas including the central nervous system, rare diseases, endocrinology, oncology, and supportive care.
Get Ipsen's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ipsen in Xcout Intel
- 27 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access